The objective of the Panel will be to provide attendees with salient information about and an understanding of international competitiveness in the context of biopharmaceuticals, survival and success in the challenging environment of 2009, presented by industry leaders representing diverse perspectives of different countries in today's market. This Panel will explore the key financial and policy features, benchmarks and differentiators of global competitiveness in biopharmaceuticals research and development, and commercialization in 2009. The Panel will examine differential product development costs in the U.S., Canada, Europe, Asia, and Latin America. It will explore what various stakeholders should do now to prepare for globalization, and will discuss foreign outsourcing and how U.S. and other biopharmaceuticals organizations and markets are approaching these issues.

• Look at differential product development costs here and abroad
• Discuss what shareholders should be doing now to prepare for globalization
• Discuss how foreign outsourcing in biopharmaceutical research and development is affecting and challenging U.S. and global biotech market environments